Aligos is a preclinical stage biotechnology company that researches and develops novel therapies for hepatologic diseases and viral infections. Read more
Aligos is a preclinical stage biotechnology company that researches and develops novel therapies for hepatologic diseases and viral infections. Read more
Co-Founder & CEO
Lawrence M. Blatt
NorthSea Therapeutics is one of Aligos Therapeutics's top competitors. NorthSea Therapeutics was founded in 2017 in Naarden, Noord-Holland. Like Aligos Therapeutics, NorthSea Therapeutics also operates in the Biotechnology industry. NorthSea Therapeutics generates $4M more revenue than Aligos Therapeutics.
Metacrine is a top competitor of Aligos Therapeutics. Metacrine was founded in 2014, and is headquartered in San Diego, California. Like Aligos Therapeutics, Metacrine also competes in the Biotechnology field. Metacrine generates $1.4M more revenue vs. Aligos Therapeutics.
Nimbus Therapeutics is seen as one of Aligos Therapeutics's top competitors. Nimbus Therapeutics is headquartered in Cambridge, Massachusetts, and was founded in 2009. Like Aligos Therapeutics, Nimbus Therapeutics also operates in the Pharmaceuticals field. Nimbus Therapeutics generates ∞% the revenue of Aligos Therapeutics.
Coming soon for Aligos Therapeutics!
Annual Revenue
No recent acquisitions found related to Aligos Therapeutics
Since Aligos Therapeutics was founded in 2018, it has participated in 3 rounds of funding. In total Aligos Therapeutics has raised $375.0M. Aligos Therapeutics' last funding round was on Oct 2020 for a total of $150.0M
Since Aligos Therapeutics was founded in 2018, it has participated in 3 rounds of funding. In total Aligos Therapeutics has raised $375.0M. Aligos Therapeutics' last funding round was on Oct 2020 for a total of $150.0M
No recent investments found related to Aligos Therapeutics
1 Corporate Drive 2nd Floor
San Francisco, California94080
Driving Directions »
